Evidence map›Paper›PMID 16002788›Full record

ArticleNucleic acids research2005

Stable transmission of targeted gene modification using single-stranded oligonucleotides with flanking LNAs.

Charlotte Andrieu-Soler, Mariana Casas, Anne-Marie Faussat, Christelle Gandolphe, Marc Doat, Denis Tempé, Carine Giovannangeli, Francine Behar-Cohen, Jean-Paul Concordet

Open access · goldAbstract readComparative Study
In one paragraph

Article in Nucleic acids research, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. LNA modification of single-stranded DNA oligonucleotides allows subtle gene modification in mismatch-repair-proficient cells.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Parameters of oligonucleotide-mediated gene modification in mouse ES cells.Journal of cellular and molecular medicine · 2010
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Charlotte Andrieu-SolerINSERM U598, Institut Biomédical des Cordeliers 15 rue de l'Ecole de Médecine, 75270 Paris Cedex 06, France.
Mariana Casas
Anne-Marie Faussat
Christelle Gandolphe
Marc Doat
Denis Tempé
Carine Giovannangeli
Francine Behar-Cohen
Jean-Paul Concordet
Inserm · FR

Funding

Genoplasty in Ocular Gene TherapyR03EY013986 · NEI · EMORY UNIVERSITY · PI NICKERSON, JOHN M · 2002 to 2004
$456k
PERMISSIVE RETINAL GENE EXPRESSION VIA HYPOMETHYLATIONR01EY012514 · NEI · EMORY UNIVERSITY · PI BOATRIGHT, JEFFREY H · 1999 to 2001
$280k
NEI NIH HHS R01 EY12514NEI NIH HHS R03 EY013986NEI NIH HHS R03 EY13986
6 · The paper itself

Abstract

Targeted mutagenesis directed by oligonucleotides (ONs) is a promising method for manipulating the genome in higher eukaryotes. In this study, we have compared gene editing by different ONs on two new target sequences, the eBFP and the rd1 mutant photoreceptor betaPDE cDNAs, which were integrated as single copy transgenes at the same genomic site in 293T cells. Interestingly, antisense ONs were superior to sense ONs for one target only, showing that target sequence can by itself impart strand-bias in gene editing. The most efficient ONs were short 25 nt ONs with flanking locked nucleic acids (LNAs), a chemistry that had only been tested for targeted nucleotide mutagenesis in yeast, and 25 nt ONs with phosphorothioate linkages. We showed that LNA-modified ONs mediate dose-dependent target modification and analyzed the importance of LNA position and content. Importantly, when using ONs with flanking LNAs, targeted gene modification was stably transmitted during cell division, which allowed reliable cloning of modified cells, a feature essential for further applications in functional genomics and gene therapy. Finally, we showed that ONs with flanking LNAs aimed at correcting the rd1 stop mutation could promote survival of photoreceptors in retinas of rd1 mutant mice, suggesting that they are also active in vivo.

Indexed as

Mutagenesis3',5'-Cyclic-GMP PhosphodiesterasesAnimalsCell LineCell SurvivalChromosomes, MammalianCyclic Nucleotide Phosphodiesterases, Type 6DNA, Single-StrandedGreen Fluorescent ProteinsLuminescent ProteinsMiceMutationOligonucleotidesOligonucleotides, AntisensePhotoreceptor Cells, VertebratePlasmids3',5'-Cyclic-GMP Phosphodiesterasesblue fluorescent protein, Aequorea victoriaCyclic Nucleotide Phosphodiesterases, Type 6DNA, Single-StrandedGreen Fluorescent Proteinslocked nucleic acidLuminescent ProteinsOligonucleotidesOligonucleotides, AntisensePde6b protein, mouse

Identifiers

PMID16002788
PMCPMC1174897
OpenAlexW1976719961

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.